Daytime intraoral neuromuscular electrical tongue stimulation using a removable device for obstructive sleep apnoea
Closed for comments This consultation ended on at Request commenting lead permission
3 Committee considerations
The evidence
3.1 NICE did a rapid review of the published literature on the efficacy and safety of this procedure. This comprised a comprehensive literature search and detailed review of the evidence from 2 sources, which was discussed by the committee. The evidence included 1 single-arm clinical trial (3 papers) and 1 pilot study. It is presented in the summary of key evidence section in the interventional procedures overview. Other relevant literature is in the appendix of the overview.
3.2 The professional experts and the committee considered the key efficacy outcomes to be: improvement in sleep apnoea, reduction in snoring and improvement in quality of life (of the person with obstructive sleep apnoea and their bed partner).
3.3 The professional experts and the committee considered the key safety outcomes to be: pain and tingling or unpleasant sensation in the mouth.
3.4 Two submissions from patient organisations about this procedure were discussed by the committee. Patient commentary was sought but none was received.
Committee comments
3.5 The committee noted that this procedure is currently only indicated for mild obstructive sleep apnoea.
Tom Clutton-Brock
Chair, interventional procedures advisory committee
November 2022
ISBN:
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions